(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Bethesda North Marriott Hotel and Conference Center

2014年3月18日 (火) 午前 8:30 - 2014年3月20日 (木) 午後 4:00

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Beginning with the End in Mind – Study Endpoints: Targeting Patient-Centered Outcomes

戻る Agenda

Study Endpoints and Patient-Centered Outcomes: Payer Needs vs. Regulatory Limits

Session Chair(s)

Paul Radensky, MD

Paul Radensky, MD

Partner

McDermott Will & Emery LLP, United States

Payers are increasingly asking for value information to support coverage and pricing decisions about new drugs and medical devices. Sometimes the data payers want do not fit squarely within the labeling of the medical product. Many were hopeful that Section 114 of FDAMA and the guidance on Patient-Reported Outcomes would reduce uncertainty about what manufacturers could communicate to payers about their products, but much uncertainty—and potential risk—remains. This talk will explore the regulatory landscape for payer communications and consider some options to bridge payer needs and regulatory limits.

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。